ID24566A - Obat untuk alopesia - Google Patents

Obat untuk alopesia

Info

Publication number
ID24566A
ID24566A IDW20000167A ID20000167A ID24566A ID 24566 A ID24566 A ID 24566A ID W20000167 A IDW20000167 A ID W20000167A ID 20000167 A ID20000167 A ID 20000167A ID 24566 A ID24566 A ID 24566A
Authority
ID
Indonesia
Prior art keywords
alopesia
medicine
seborrhea
alopecia
chem
Prior art date
Application number
IDW20000167A
Other languages
English (en)
Indonesian (id)
Inventor
Koichi Kojima
Takakazu Hamada
Shiroh Yosioka
Original Assignee
Sankyo Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co filed Critical Sankyo Co
Publication of ID24566A publication Critical patent/ID24566A/id

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J73/00—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms
    • C07J73/001—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms by one hetero atom
    • C07J73/005—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms by one hetero atom by nitrogen as hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/28—Antiandrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicinal Preparation (AREA)
IDW20000167A 1997-07-29 1998-07-27 Obat untuk alopesia ID24566A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP20313697 1997-07-29

Publications (1)

Publication Number Publication Date
ID24566A true ID24566A (id) 2000-07-27

Family

ID=16469018

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW20000167A ID24566A (id) 1997-07-29 1998-07-27 Obat untuk alopesia

Country Status (21)

Country Link
US (1) US6380179B1 (de)
EP (1) EP0998930B1 (de)
KR (1) KR20010022066A (de)
CN (1) CN1129433C (de)
AT (1) ATE262337T1 (de)
AU (1) AU733830B2 (de)
BR (1) BR9811293A (de)
CA (1) CA2298851A1 (de)
DE (1) DE69822636T2 (de)
DK (1) DK0998930T3 (de)
ES (1) ES2218840T3 (de)
HU (1) HUP0003159A3 (de)
ID (1) ID24566A (de)
IL (1) IL134199A0 (de)
NO (1) NO20000469L (de)
NZ (1) NZ502537A (de)
PL (1) PL338414A1 (de)
PT (1) PT998930E (de)
RU (1) RU2193887C2 (de)
TR (1) TR200000263T2 (de)
WO (1) WO1999006050A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE265854T1 (de) * 1997-02-26 2004-05-15 Sankyo Co Azasteroidverbindung zur behandlung oder vorbeugung von prostatakrebs
WO2005074985A2 (en) * 2004-02-02 2005-08-18 Schering Corporation Methods of modulating cd200 and cd200r
PL1898867T3 (pl) * 2005-06-24 2018-02-28 Arizona Board Of Regents, Acting On Behalf Of The University Of Arizona Sposób leczenia zaburzeń wzrostu włosów, takich jak łysienie androgenowe typu kobiecego, i użyteczne kompozycje
US20080108681A1 (en) * 2006-10-27 2008-05-08 Access Business Group International Llc Use of allantoin as a pro-collagen synthesis agent in cosmetic compositions
US20120245205A1 (en) 2009-07-29 2012-09-27 Delong Mitchell A Compositions and methods for inhibiting hair growth
MX2010012945A (es) * 2010-11-24 2012-05-24 Fidel Ojeda Gomez Una formula para el control y eliminacion de seborrea y alopecia en el cuero cabelludo.
RU2477155C2 (ru) * 2011-04-27 2013-03-10 Закрытое акционерное общество "Патент-Фарм" Способ лечения андрогенетической алопеции

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5571817A (en) 1984-02-27 1996-11-05 Merck & Co., Inc. Methods of treating androgenic alopecia with finasteride [17β-N-mono-substituted-carbamoyl-4-aza-5-α-androst-1-en-ones]
US5516768A (en) 1990-03-16 1996-05-14 Smithkline Beecham Corporation Uncompetitive inhibition of steroid and 5α-reductose
IE76452B1 (en) 1990-10-29 1997-10-22 Sankyo Co Azasteroid compounds for the treatment of prostatic hypertrophy their preparation and use
JP3030152B2 (ja) * 1992-02-03 2000-04-10 三共株式会社 ４−アザステロイド化合物
US5278159A (en) * 1992-10-06 1994-01-11 Merck & Co., Inc. Aryl ester derivatives of 3-oxo-4-aza-androstane 17-β-carboxylates as 5-α-reductase inhibitors
US5486511A (en) * 1993-05-25 1996-01-23 Merrell Dow Pharmaceuticals Inc. 4-amino-17β-(cyclopropyloxy)androst-4-en-3-one, 4-amino-17β-(cyclopropylamino)androst-4-en-3-one and related compounds as C17-20 lyase and 5α-reductase
TW382595B (en) 1993-10-15 2000-02-21 Merck & Co Inc Pharmaceutical composition for use in arresting and reversing androgenic alopecia
JPH0873492A (ja) * 1994-06-28 1996-03-19 Sankyo Co Ltd アザステロイド類
US5629007A (en) 1995-03-21 1997-05-13 Eli Lilly And Company Method of preventing prostatic cancer development
US5635197A (en) 1995-03-21 1997-06-03 Eli Lilly And Company Treatment and prevention of prostatic cancer metastasis
JPH11513380A (ja) 1995-09-27 1999-11-16 メルク エンド カンパニー インコーポレーテッド ５−αレダクターゼ阻害剤によるアンドロゲン性脱毛症の予防方法
HUP9901870A3 (en) * 1996-02-05 1999-11-29 Sankyo Company Ltd Chuo Ku 5alfa-reductase inhibitory preparation for oral administration, process for producing the same, and use thereof
ATE265854T1 (de) * 1997-02-26 2004-05-15 Sankyo Co Azasteroidverbindung zur behandlung oder vorbeugung von prostatakrebs
US6093722A (en) 1997-02-26 2000-07-25 Sankyo Company, Limited Method for treating prostate cancer

Also Published As

Publication number Publication date
BR9811293A (pt) 2000-08-29
EP0998930B1 (de) 2004-03-24
NZ502537A (en) 2002-11-26
PL338414A1 (en) 2000-11-06
CN1129433C (zh) 2003-12-03
WO1999006050A1 (en) 1999-02-11
DK0998930T3 (da) 2004-04-26
NO20000469D0 (no) 2000-01-28
PT998930E (pt) 2004-05-31
TR200000263T2 (tr) 2000-09-21
AU733830B2 (en) 2001-05-24
EP0998930A1 (de) 2000-05-10
HUP0003159A3 (en) 2001-07-30
CA2298851A1 (en) 1999-02-11
HUP0003159A2 (hu) 2001-04-28
KR20010022066A (ko) 2001-03-15
EP0998930A4 (de) 2002-06-12
IL134199A0 (en) 2001-04-30
US6380179B1 (en) 2002-04-30
CN1271285A (zh) 2000-10-25
HK1027290A1 (en) 2001-01-12
DE69822636D1 (de) 2004-04-29
ATE262337T1 (de) 2004-04-15
NO20000469L (no) 2000-03-28
ES2218840T3 (es) 2004-11-16
AU8358598A (en) 1999-02-22
RU2193887C2 (ru) 2002-12-10
DE69822636T2 (de) 2005-01-05

Similar Documents

Publication Publication Date Title
EP1206937A4 (de) Nikroimidazolpräparationen zur äusseren anwendung zur behandlung der dermatose
PT918776E (pt) Sintese total de acilfulvenos antitumorais
MX9800718A (es) Derivados de 2-(4-substituidos)-bencilamino-2-metil- propanamida.
BG104569A (en) Substituted 2-benzylamino-2-phenyl-acetamide compounds
ID24566A (id) Obat untuk alopesia
NO981393L (no) Guanidinoproteasehemmere
MX9805023A (es) Derivados de 1-metilcarbapenem.
AU681021B2 (en) Indole derivative and medicine containing the same
HRP20010885B1 (en) Ethanesulfonyl-piperidine derivatives
NO994107D0 (no) Preparater for behandling eller forhindring av prostatakreft
ATE196910T1 (de) 7-glykosyloxybenzopyranderivat und dieses enthaltendes antiallergisches mittel
EP0997457A4 (de) 3-benzoylindol-derivate und sie enthaltende medikamente
DE69528984D1 (de) Hemmung der leukotrienbiosynthese mittels harnstoffderivaten
ATE206699T1 (de) Uch-15-verbindungen
AU4544096A (en) New derivatives of glycylanilides, preparation and therapeutical application